Submitted:
25 May 2025
Posted:
26 May 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Diffusion as Information Flow
3. Compartments as Cognitive Modules
4. Channels as Logic Gates: Concept and Mechanism
4.1. Logic Gate Analogy
- Inputs: Substrate concentrations or membrane potentials
- Gate: Transporter or channel, which opens/closes based on specific conditions
- Output: Presence (1) or absence (0) of a metabolite in the target compartment
4.2. Key Transporters as Logic Gates
- Inputs: Cytosolic pyruvate concentration, MPC activity
- Output: Pyruvate flux into mitochondria (TCA cycle activation)
- Mathematics: Follows Michaelis–Menten kinetics
- -
- J: Flux of metabolite through the channel (mol/s)
- -
- : Maximum transport rate
- -
- : Substrate concentration at half-maximum flux
- -
- [S]: Substrate concentration (e.g., pyruvate in cytosol)
- -
- : Free energy change (influenced by ΔΨ)
- -
- : Gas constant (8.314 J )
- -
- T: Temperature (310 K)
- Inputs: Very long-chain fatty acids (VLCFAs) and ABCD1 expression
- Output: Fatty acid import into peroxisomes for β-oxidation
- Logic: Transport occurs if either substrate concentration is high OR transporter is upregulated.
- Inputs: Cytosolic folate and transporter expression
- Output: Folate delivery to mitochondria, enabling one-carbon metabolism and NADPH production
4.3. Gating Logic as Computation

6. Implications for Disease and Therapy
6.1. X-Linked Adrenoleukodystrophy (X-ALD)
6.2. Autism Spectrum Disorder (ASD)
6.3. Type 2 Diabetes and the Logic of Pyruvate Misrouting
- Cytosolic glucose accumulation, which leads to carbon shunting into the polyol pathway, increasing sorbitol and oxidative stress [19].
- Enhanced branched-chain amino acid (BCAA) catabolism, mediated by AMPK and mTOR signaling, suggesting that targeted MPC inhibition reprograms energy substrate use to alleviate diabetic phenotypes [20].
- Reduced acetyl-CoA generation, impairing one-carbon metabolism and diminishing the capacity for myelin synthesis and repair [15].
7. Therapeutic Framework: Restoring Intracellular Awareness
- Identification of Core Substrate Flow Deficits:Determine which intracellular metabolites (e.g., folate, NAD⁺, glutamate, pyruvate) are failing to reach their target compartments due to transporter suppression or gating collapse. These deficits represent primary informational bottlenecks in cellular awareness.
- Transcriptional Equivalency Mapping:Analyze compensatory transcription patterns to identify which transporters or enzymes are being downregulated or upregulated in an attempt to reroute metabolic flow. This reveals the cell’s current logic state—and its attempt to restore coherence.
- Therapeutic Reprogramming of Gating Architecture:Restore substrate availability through precision nutrient supplementation, while increasing metabolic resistance (e.g., NAD⁺, ATP, folate tension) to activate feedback loops that upregulate necessary transporters and enzymes. This encourages the cell to reorganize its transporter and enzyme network, recovering the lost biochemical logic.
8. The Cell as a Biochemical Computer
9. Limitations and Future Directions
10. Conclusions
Acknowledgments
References
- A. Pandi o.fl., „Metabolic perceptrons for neural computing in biological systems“, Nat. Commun., b. 10, tbl. 1, 2019.
- Z. Chen o.fl., „De novo design of protein logic gates“, Science (80-. )., b. 368, tbl. 6486, 2020.
- A. Danchin og A. Sekowska, „The logic of metabolism and its fuzzy consequences“, Environmental Microbiology, b. 16, tbl. 1. 2014. [CrossRef]
- T. Bender, G. Pena, og J. Martinou, „Regulation of mitochondrial pyruvate uptake by alternative pyruvate carrier complexes“, EMBO J., b. 34, tbl. 7, 2015.
- J. Wang o.fl., „UK-5099, a mitochondrial pyruvate carrier inhibitor, recovers impaired neutrophil maturation caused by AK2 deficiency in human pluripotent stem cell models“, Biochem. Biophys. Res. Commun., b. 687, 2023.
- V. Shoshan-Barmatz, V. De Pinto, M. Zweckstetter, Z. Raviv, N. Keinan, og N. Arbel, „VDAC, a multi-functional mitochondrial protein regulating cell life and death“, Molecular Aspects of Medicine, b. 31, tbl. 3. 2010. [CrossRef]
- Z. P. Chen o.fl., „Structural basis of substrate recognition and translocation by human very long-chain fatty acid transporter ABCD1“, Nat. Commun., b. 13, tbl. 1, 2022.
- M. Z. Peng o.fl., „Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism“, Cell. Mol. Life Sci., b. 79, tbl. 7, 2022.
- J. Berger, S. Forss-Petter, og F. S. Eichler, „Pathophysiology of X-linked adrenoleukodystrophy“, Biochimie, b. 98, tbl. 1. 2014. [CrossRef]
- J. Liu o.fl., „Association between genetic variants in SLC25A12 and risk of autism spectrum disorders: An integrated meta-analysis“, Am. J. Med. Genet. Part B Neuropsychiatr. Genet., b. 168, tbl. 4, 2015.
- D. M. E. I. Hellebrekers o.fl., „Novel SLC25A32 mutation in a patient with a severe neuromuscular phenotype“, Eur. J. Hum. Genet., b. 25, tbl. 7, 2017.
- M. J. Rigby o.fl., „Increased expression of SLC25A1/CIC causes an autistic-like phenotype with altered neuron morphology“, Brain, b. 145, tbl. 2, 2022.
- E. Szabó o.fl., „Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients“, Sci. Rep., b. 11, tbl. 1, 2021.
- C. Rong, X. Cui, J. Chen, Y. Qian, R. Jia, og Y. Hu, „DNA methylation profiles in placenta and its association with gestational diabetes mellitus“, Exp. Clin. Endocrinol. Diabetes, b. 123, tbl. 5, 2015. [CrossRef]
- N. Ismail o.fl., „Vitamin B5 (D-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis“, Biochem. Biophys. Res. Commun., b. 522, tbl. 1, 2020.
- S. Porasuphatana, S. Suddee, A. Nartnampong, J. Konsil, B. H. Busakorn, og A. Santaweesuk, „Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alphalipoic acid: A randomized double-blinded placebocontrolled study“, Asia Pac. J. Clin. Nutr., b. 21, tbl. 1, 2012.
- Y. Zhang o.fl., „Influence of biotin intervention on glycemic control and lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis“, Frontiers in Nutrition, b. 9. 2022.
- D. E. Kelley, J. He, E. V. Menshikova, og V. B. Ritov, „Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes“, Diabetes, b. 51, tbl. 10, 2002. [CrossRef]
- P. S. Chitra o.fl., „Status of oxidative stress markers, advanced glycation index, and polyol pathway in age-related cataract subjects with and without diabetes“, Exp. Eye Res., b. 200, 2020.
- K. S. McCommis og B. N. Finck, „The Hepatic Mitochondrial Pyruvate Carrier as a Regulator of Systemic Metabolism and a Therapeutic Target for Treating Metabolic Disease“, Biomolecules, b. 13, tbl. 2. 2023.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).